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ABSTRACT 
The most important differential diagnosis of chromophobe renal cell carcinoma is renal 
oncocytoma. Due to overlapping morphological characteristics of renal oncocytoma and 
chromophobe renal cell carcinoma, particularly its eosinophilic variant, making a correct 
diagnosis can be challenging. To date no data are available on the presence of the tumor 
fibrous capsule as a diagnostic feature in differentiating these tumors. The main purpose of 
this study was to establish the presence and compare the thickness of the tumor fibrous 
capsule between two tumor groups. A total of 37 tumors-18 cases of chromophobe renal cell 
carcinoma (3 eosinophilic and 15 classic) and 19 cases of renal oncocytoma-were analyzed. 
Four slides of each tumor stained with hematoxylin and eosin were first scanned at low-power 
magnification (X40) to assess the presence of the capsule. If present, capsule was measured in 
three different, thickest areas at higher magnification (X200). The mean value of capsule 
thickness was calculated and taken into consideration. Capsule was present in 12 (66.7%) 
cases of CRCCs and in only 2 (10.5%) cases of renal oncocytomas.  Statistical analysis 
showed significant difference between the presence of fibrous capsule in these two observed 
tumor groups (P=0.001). Average thickness of capsule in CRCCs was 337.7 μm, and 115.4 
μm in renal oncocytomas, but the median was not statistically significant (P=0.198). Studies 
with a larger number of cases are needed to conclude if this characteristic could be a low-cost, 
reliable microscopic feature in differentiating between chromophobe renal cell carcinoma and 
renal oncocytoma. 
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INTRODUCTION  
In the current World Health Organization (WHO) classification of renal tumors, chromophobe 
renal cell carcinoma (CRCC) is recognized as a malignant renal cell neoplasm derived from 
the intercalated cell of the collecting duct, which accounts for 5% of renal epithelial tumors 
[1]. Two main variants are classic and eosinophilic CRCC. Although considered less 
aggressive than other renal cell carcinomas, CRCC has a metastatic potential and may 
undergo sarcomatoid transformation, which is associated with more aggressive behavior [1]. 
Renal oncocytoma is a benign tumor, which shares a common cellular origin with CRCC and 
represents 3% to 9% of all primary renal tumors [1]. Due to overlapping morphological 
characteristics of renal oncocytoma and CRCC, particularly its eosinophilic variant with the 
abundant granular eosinophilic cytoplasm, making a correct diagnosis can be challenging. In 
recent years, much effort has been made to identify immunohistochemical markers that could 
be useful in differentiating between CRCC and renal oncocytoma [2-6]. However, final 
decision about the appropriate panel of immunohistochemical markers for the differential 
diagnosis of CRCC and renal oncocytoma is still being discussed.  Hale's iron stain can be 
particularly useful in differentiating these tumors but many laboratories have found this stain 
to be technically challenging and present with variable results [3]. Other authors have 
attempted to make the distinction on account of nuclear morphometric measurements and 
features, with the conclusion that a combination of hyperchromatic wrinkled nuclei and 
perinuclear halos is more often associated with CRCC [7-10]. CRCC is, like cases of clear 
cell renal carcinoma, according to our experience, in the majority of cases surrounded by a 
fibrous capsule, which separates the tumor tissue from the surrounding renal parenchyma. 
Unlike CRCC, renal oncocytoma, despite being a benign tumor, lacks the fibrous capsule in a 
number of cases. The main purpose of this study was to establish the presence and compare 
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the thickness of the tumor fibrous capsule between two tumor groups. According to the 
English literature there are no data on similar research in this field.  
 
PATIENTS AND METHODS 
 
Patients 
The files from two Departments of Pathology (Ljudevit Jurak University Department of 
Pathology, Sestre milosrdnice University Hospital and Department of Pathology, University 
Hospital Dubrava, Zagreb) from the period between 1999-2008 were searched for cases of 
histologically confirmed CRCC and renal oncocytoma. All cases were reviewed and diagnosis 
of CRCC and renal oncocytoma was established according to the criteria proposed by 2004 
WHO for classification of renal tumors [11]. There were 37 cases in total: 18 (3 eosinophilic 
and 15 classic) CRCCs and 19 renal oncocytomas. Four slides of each tumor, stained with 
hematoxylin and eosin were analyzed. Among patients with CRCC, 10 were females, and 8 
males. Patients’ age ranged from 34-76 years (mean 56.9). Tumor size ranged from 1.7-17 cm 
(mean 7.9). Nuclear grade for CRCC was assessed according to the Fuhrman classification 
system (12).  There were 10 CRCCs with G2, 7 with G3 and 1 with G4 nuclear grade. Among 
patients with renal oncocytoma, 12 were females, and 7 males. Patients’ age ranged from 47-
80 years (mean 65.2). Tumor size ranged from 0.9-8 cm (mean 3.6). 
 
Methods 
We analyzed the presence of the tumor fibrous capsule and measured its thickness in the cases 
of CRCCs and renal oncocytomas. Four slides of each tumor were first scanned at low-power 
magnification (X40) to assess the presence of tumor fibrous capsule. If present, capsule was 
measured in three different, thickest areas at higher magnification (X200).  Morphometric 
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measurements of capsule were done by computerized morphometry system with an Olympus 
microscope BX51, QuickPHOTO Pro software and an Olympus Camedia C-5050 camera and 
were expressed in micrometers (μm). The mean value of capsule thickness was calculated and 
taken into consideration. All samples were examined independently by three observers and 
any difference was resolved by a joint review. Statistical analysis was performed using Chi-
Square test, Spearman's correlation test, Fisher's exact test and Mann-Whitney test. The level 
of statistical significance was set as P<0.05. 
 
RESULTS 
The main clinical and morphometric findings are summarized in Tables 1 and 2. Capsule was 
present in 12 cases (66.7%) of CRCCs and in only 2 cases (10.5%) of renal oncocytomas 
(Figure 1).  Statistical analysis showed significant difference between the presence of fibrous 
capsule in these two observed tumor groups (P=0.001). The capsule in CRCCs was found to 
encompass the whole tumor circumference on the examined slides, while in cases of ROs with 
capsule it was formed only partially. Seven cases (36.8%) of ROs featured a grossly visible 
star-shaped central scar, but there was no surrounding fibrous capsule in any of them. 
Average thickness of capsule in CRCCs was 337.7 μm, and 115.4 μm in renal oncocytomas 
but the median was not statistically significant (P=0.198). The correlation between tumor size, 
nuclear grade and capsular presence in CRCCs showed no statistically significant differences 
(P=0.616, P=0.091, respectively). When comparing capsule thickness with tumor size, and 
nuclear grade in CRCCs, no statistically significant differences were found (P=0.688, 
P=0.533, respectively). Mean tumor size was higher in CRCCs (7.9 cm) than in renal 
oncocytomas (3.6 cm). Patients with renal oncocytoma were significantly older compared to 
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patients with CRCC (P=0.021). Significant difference in distribution of these two tumor types 
between male and female was not found (P=0.743). 
 
DISCUSSION 
The most important differential diagnosis of CRCC is renal oncocytoma. Their distinction is 
essential since CRCC has malignant potential whereas renal oncocytoma is a benign tumor. 
Moreover, cases of sarcomatoid transformation of CRCC emphasize the importance of 
making the accurate diagnosis due to more aggressive behavior of this type of CRCC [1,13-
15]. CRCCs and renal oncocytomas have overlapping morphologic, immunohistochemical, 
histochemical and ultrastructural characteristics. Preoperative physical and radiographic 
examinations are not reliable in distinguishing renal oncocytoma from CRCC, which makes 
the accurate diagnosis for pathologists even more complicated [16,17]. Also, the conclusions 
of studies concerning fine-needle aspiration biopsy results in differentiating these tumors are 
inconsistent [18-20]. Thus, in the majority of cases the final diagnosis is made after a 
histopathological evaluation. Under the light microscope the most important discriminating 
characteristics are nuclear and cytologic features. Renal oncocytoma has homogeneous 
nuclear size, round nuclear contours, common binucleation and discrete nucleoli. However, 
CRCC in some cases can also have similar appearance although more often with 
hyperchromatic wrinkled nuclei and perinuclear halos [10]. Entrapped normal tubules in the 
central or peripheral parts of the tumor could also be the clue to the diagnosis of renal 
oncocytoma [2]. In the majoritiy of cases, however, a definitive diagnosis can still not be 
rendered based on these criteria under the light microscope evaluation only. Much effort has 
been made to identify immunohistochemical markers that could be useful in differentiating 
between CRCC and renal oncocytoma, such as caveolin-1, CD63, anti-mitochondrial 
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antibody, cytokeratin 14, cytokeratin 7, vimentin, glutathione S-transferase α, CD10, CD117, 
claudin-7, claudin-8 and kidney-specific cadherin [2-6].  Antimitochondrial antibodies and 
parvalbumin are considered to be excellent markers for differentiating between these tumors 
[21-23]. Also the combination of three immunohistochemical markers: vimentin, glutathione 
S-transferase α and epithelial cell adhesion molecule is highly sensitive and specific for the 
differential diagnosis of CRCC and renal oncocytoma [4]. Hale's iron stain continues to be a 
useful histochemical marker in differentiating between these tumors but many laboratories 
have found it technically challenging and with variable results [3].  Brunelli et al. [24] 
analyzed a group of 10 renal oncocytomas and 19 CRCCs by fluorescence in situ 
hybridization to clarify the genetic lesions of these tumors and revealed that detection of 
losses of chromosomes 2, 6, 10 and 17 could support the diagnosis of CRCC over a renal 
oncocytoma. These conclusions will hopefully lead to a better understanding of different 
patterns of genetic anomalies and facilitate the differential diagnosis between CRCC and renal 
oncocytoma. According to our experience, in a number of cases, CRCC was found to be 
surrounded by a fibrous capsule, which separates the tumor tissue from adjecent renal 
parenchyma. When compared with renal oncocytoma statistically significant difference in the 
presence of the fibrous capsule in the two observed tumor groups was striking. Even though 
the capsule in oncocytomas, when present, was less thick than in CRCCs, the median was not 
statistically significant due to a small number of cases. In somewhat older literature, 
surrounding capsule of variable thickness was reported to be a feature of typical oncocytoma 
[25]. However, in the last World Health Organization classification of kidney tumors, 
oncocytomas are defined as well-circumscribed, nonencapsulated neoplasms [11]. 
Interestingly, no data are available on the presence of the tumor fibrous capsule as a 
diagnostic feature in differentiating these tumors. Shimasaki et al. [26] studied the 
participation of myofibroblasts in the capsular formation of renal cell carcinomas, with only 
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two cases of CRCC, and concluded that myofibroblasts may participate in the capsular 
formation of conventional and CRCC. To date there are no data on similar research regarding 
renal oncocytoma and comparative analysis with CRCC. Our results show that the capsule is 
significantly more common and thicker in chromophobe renal cell carcinomas compared to 
renal oncocytomas. Studies with a larger number of cases are needed to conclude if this 
characteristic could be a low-cost, reliable microscopic feature in differentiating between 
CRCC and renal oncocytoma. 
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Table 1. Clinical, histological and morphometric findings in chromophobe renal cell        
carcinoma 
 
 
 
 
 
 
 
Case Age Gender Tumor size (cm) Type 
Nuclear 
grade Capsule 
Capsule 
thickness 
(μm) 
 
1 55 F 6.5 classic G2 + 83.2 
2 53 F 12 classic G2 + 295 
3 60 F 12 classic G2 + 175.7 
4 63 M 10 eosinophilic G2 + 85.1 
5 47 F 1.7 classic G3 + 380.4 
6 46 M 5.5 classic G3 + 218.4 
7 60 F 7 eosinophilic G2 + 507.9 
8 47 F 17 eosinophilic G4 + 562.2 
9 58 M 3 classic G2 + 551.4 
10 51 F 8 classic G2 -  
11 66 M 6.2 classic G3 + 238.5 
12 76 M 4.5 classic G2 -  
13 49 F 7.5 classic G3 + 565.5 
14 75 M 11 classic G3 + 623.6 
15 34 F 12 classic G3 -  
16 52 M 6 classic G2 -  
17 56 F 5.5 classic G2 -  
18 76 M 7.2 classic G3 -  
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Table 2. Clinical and morphometric findings in renal oncocytoma 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Case Age Gender Tumor size (cm) Capsule 
Capsule thickness 
(μm) 
 
1 70 F 1.5 + 120.7 
2 54 F 3 + 110.1 
3 79 F 2.5 -  
4 57 M 4 -  
5 68 F 2.2 -  
6 62 F 3 -  
7 68 M 3 -  
8 70 F 6.5 -  
9 77 M 0.9 -  
10 61 F 1.7 -  
11 55 F 8 -  
12 80 F 6 -  
13 47 M 4.3 -  
14 74 F 2.6 -  
15 52 M 6 -  
16 72 M 3.5 -  
17 69 F 2 -  
18 66 M 3 -  
19 58 F 4.2 -  
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Figure 1 Chromophobe renal cell carcinoma (a) and renal oncocytoma (b) surrounded by 
fibrous capsule.  Chromophobe renal cell carcinoma (c) and renal oncocytoma (d) without 
fibrous capsule (X100, HE). 
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